UNI-EN 42:Notification for technical error correction
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 42 | / | 2020 | |||||||
| Date of issue: | 2020-06-18 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification for technical error correction | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, June 18, 2020 - According to the requirements of art. 111, para. 8 of LPOS “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that due to a technical error in the Notification for treasury shares, number 194-00-31 / 16.06.2020 should be read: “Sofia, Bulgaria, June 16, 2020 - According to the requirements of art. 111, para. 8 of LPOS “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 15, 2020 the Company sold 85 748 own shares representing 0.0636% of the share capital of the Company, at a total value of 277 823,52 BGN on the Bulgarian Stock Exchange, the average price per share was 3.240 BGN. The total number of treasury shares after this transaction is 9 114 467, representing 6.762% of the share capital of the Company.” We apologize for the inconvenience. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_15062020_Buy_back_EN_correction.pdf 3JR_15062020_Buy_back_EN_correction.pdf | Notification for technical error correction | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2020-06-18 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 13.8 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
